Revisiting deficits in threat and safety appraisal in obsessive-compulsive disorder.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 Dec 2023
Historique:
revised: 22 08 2023
received: 19 04 2023
accepted: 02 10 2023
medline: 29 11 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Current behavioural treatment of obsessive-compulsive disorder (OCD) is informed by fear conditioning and involves iteratively re-evaluating previously threatening stimuli as safe. However, there is limited research investigating the neurobiological response to conditioning and reversal of threatening stimuli in individuals with OCD. A clinical sample of individuals with OCD (N = 45) and matched healthy controls (N = 45) underwent functional magnetic resonance imaging. While in the scanner, participants completed a well-validated fear reversal task and a resting-state scan. We found no evidence for group differences in task-evoked brain activation or functional connectivity in OCD. Multivariate analyses encompassing all participants in the clinical and control groups suggested that subjective appraisal of threatening and safe stimuli were associated with a larger difference in brain activity than the contribution of OCD symptoms. In particular, we observed a brain-behaviour continuum whereby heightened affective appraisal was related to increased bilateral insula activation during the task (r = 0.39, p

Identifiants

pubmed: 37853935
doi: 10.1002/hbm.26518
pmc: PMC10681637
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6418-6428

Subventions

Organisme : National Health and Medical Research Council

Informations de copyright

© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742):
pubmed: 29352025
Behav Genet. 2010 Jul;40(4):505-17
pubmed: 20361247
J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):64-77
pubmed: 31589909
Neuroimage. 2012 Jul 16;61(4):1277-86
pubmed: 22484411
Hum Brain Mapp. 2022 Feb 1;43(2):733-749
pubmed: 34811847
Brain. 2023 Apr 19;146(4):1322-1327
pubmed: 36380526
Psychol Med. 2019 Jan;49(2):278-286
pubmed: 29622050
JAMA. 2017 Apr 4;317(13):1358-1367
pubmed: 28384832
Neurosci Biobehav Rev. 2020 Jan;108:254-268
pubmed: 31747553
Neuroimage. 2009 Mar 1;45(1):208-14
pubmed: 19100329
J Exp Psychol Anim Behav Process. 2010 Oct;36(4):495-500
pubmed: 20973611
Neuroimage. 2017 May 15;152:12-18
pubmed: 28254509
Front Neuroinform. 2011 Aug 22;5:13
pubmed: 21897815
J Neurosci. 2008 Nov 5;28(45):11517-25
pubmed: 18987188
Nat Neurosci. 2020 Nov;23(11):1421-1432
pubmed: 32989295
Clin Psychol Rev. 2015 Dec;42:72-82
pubmed: 26319194
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Psychol Med. 1990 Aug;20(3):465-9
pubmed: 2236357
Neurosci Biobehav Rev. 2021 Aug;127:659-674
pubmed: 34023357
Neuroimage. 2018 Feb 1;166:152-166
pubmed: 29066396
Neurosci Biobehav Rev. 2021 Oct;129:75-94
pubmed: 34314751
Psychol Med. 2022 Oct;52(14):3267-3279
pubmed: 33557980
Front Neuroinform. 2014 Feb 21;8:14
pubmed: 24600388
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
Hum Brain Mapp. 2023 Dec 15;44(18):6418-6428
pubmed: 37853935
Neuroimage. 2020 Feb 15;207:116427
pubmed: 31801684
Biol Psychiatry. 2013 Feb 15;73(4):321-8
pubmed: 23200527
Psychol Med. 2021 Jul;51(10):1657-1665
pubmed: 32138800
Mol Psychiatry. 2022 Feb;27(2):784-786
pubmed: 34667263
Arch Gen Psychiatry. 2009 Nov;66(11):1189-200
pubmed: 19884607
Brain. 2009 Apr;132(Pt 4):853-68
pubmed: 18952675
Compr Psychiatry. 2021 Apr;106:152223
pubmed: 33618297
JAMA Psychiatry. 2013 Jun;70(6):608-18; quiz 554
pubmed: 23740049
JAMA Psychiatry. 2020 Jun 1;77(6):618-627
pubmed: 32022832
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221
pubmed: 28265059
J Behav Ther Exp Psychiatry. 1994 Mar;25(1):49-59
pubmed: 7962581
Neuroimage. 2021 Dec 15;245:118643
pubmed: 34699966
Neuroimage. 2011 May 15;56(2):455-75
pubmed: 20656037
Neurosci Biobehav Rev. 2018 May;88:16-25
pubmed: 29530516
Neuroimage. 2004;23 Suppl 1:S250-63
pubmed: 15501095
Behav Res Ther. 2021 Sep;144:103927
pubmed: 34237645
Am J Psychiatry. 2005 Feb;162(2):228-38
pubmed: 15677583
Neuroimage. 2014 Jul 15;95:232-47
pubmed: 24657355
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881

Auteurs

Luke J Hearne (LJ)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Michael Breakspear (M)

College of Engineering Science and Environment, College of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia.

Ben J Harrison (BJ)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.

Caitlin V Hall (CV)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Hannah S Savage (HS)

College of Engineering Science and Environment, College of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia.

Conor Robinson (C)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Saurabh Sonkusare (S)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Emma Savage (E)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Zoie Nott (Z)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Leo Marcus (L)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Sebastien Naze (S)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Bjorn Burgher (B)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Andrew Zalesky (A)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.

Luca Cocchi (L)

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH